The Influence of Compound Eosinophil-Lactobacillus Tablets on Neonatal Hyperbilirubinemia
JIANG De-lin
XIE Rong
LIU Ji-tian
Abstract：Objective:To investigate the necessity of prevention of neonatal hyperbilirubinemia in the early administration of Compound Eosinophil-Lactobacillus Tablets.Method:328 term healthy newborn infants born in the Central Hospital of Yongzhou city from Jannuary 2014 to December 2014 were randomly divided into the observation group(n=168) and the control group(n=160) by double blind method.The observation group was given oral Compound Eosinophil-Lactobacillus Tablets after birth,the control group not to add any probiotics,the serum total bilirubin level and the incidence of hyperbilirubinemia of the two groups were compared.Result:Before the intervention,there was no significant difference between the two groups in the level of total bilirubin(P>0.05), after the intervention,the difference between the two groups was statistically significant(P<0.05).The observation group of 21 cases of hyperbilirubinemia, 52 patients in the control group,there was significant difference between two groups(P<0.05).Conclusion:Compound Eosinophil-Lactobacillus Tablets is on the prevention of neonatal hyperbilirubinemia.
Keywords：Compound Eosinophil-Lactobacillus TabletsHealthy full-term infantsPreventionHyperbilirubinemia
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 15-15,16 )